Thus, we could speculate that the effects of the IL-6 system on frailty, especially sarcopenia, may involve their contribution to lean body mass decrease, bone mineral density decrease, anemia, thrombocytosis, cholesterol and albumin decrease, insulin resistance, and cognitive impairment. This evidence concerns the gene IL6 and anemia.